Recommended Doses for Rapid Sequence Intubation in Obese Patients
For rapid sequence intubation in obese adults, use fentanyl 100-150 mcg (or 1-2 mcg/kg), rocuronium 1.0 mg/kg based on actual body weight, and midazolam 2-5 mg. 1
Fentanyl Dosing
Administer fentanyl 100-150 mcg intravenously to suppress laryngeal reflexes and provide optimal intubation conditions 1. Alternative dosing of 1-2 mcg/kg can be used 2. The pediatric literature suggests higher doses (1-5 mcg/kg) are often recommended for intubation, though rapid administration may cause chest wall rigidity when a muscle relaxant is co-administered 2.
- Fentanyl onset is 1-2 minutes with duration of 30-60 minutes 3
- Initial dose typically 50-100 mcg for endoscopic procedures, but RSI requires higher doses 3
- Respiratory depression risk increases when combined with benzodiazepines 3, 2
Rocuronium Dosing
Dose rocuronium at 1.0 mg/kg based on actual body weight in obese patients 4. This is critical—the 2020 Anaesthesia guidelines specifically recommend against using ideal or lean body weight for rocuronium in obesity, as this produces poor intubation conditions 4.
The FDA label supports 0.6-1.2 mg/kg for rapid sequence intubation 5, and recent research suggests doses ≥1.4 mg/kg may improve first-attempt success with direct laryngoscopy without increasing adverse events 6. However, the standard 1.0 mg/kg dose provides excellent intubating conditions when dosed by actual body weight 4.
Key considerations:
- Rocuronium provides neuromuscular blockade sufficient for intubation in median time of 1 minute 5
- Have sugammadex immediately available for "cannot intubate/cannot oxygenate" scenarios 1
- Non-depolarizing muscle relaxants like rocuronium are water-soluble and distribute in lean mass, but the exception is dosing for intubation in obesity where actual body weight is used 4
Midazolam Dosing
Administer midazolam 2-5 mg intravenously with etomidate or propofol for induction 1.
- Onset is 1-2 minutes with peak effect at 3-4 minutes 3
- Duration 15-80 minutes 3
- Clearance is reduced in obese patients 3
- When used with opioids, synergistic interaction occurs—dose reduction may be indicated 3
- For RSI specifically, 0.2 mg/kg (maximum 20 mg) has been used in pediatric protocols 2
Important caveat: Lower doses of midazolam (0.2 mg/kg) are ineffective for RSI—allow 2-3 minutes for effect before administering muscle relaxant 2. The 2-5 mg adult dose from the Chinese Society guidelines represents a more conservative approach suitable for hemodynamically unstable patients 1.
Critical Safety Considerations for Obese Patients
Obese patients have extremely short apnea oxygenation times 1. Research shows succinylcholine produces faster desaturation (283 seconds) compared to rocuronium (329 seconds) in overweight patients during RSI 7. Great effort is needed to avoid severe hypoxemia 1.
Dosing pitfalls to avoid:
- Do NOT dose rocuronium by ideal or lean body weight—this results in inadequate paralysis, resistance to laryngoscope insertion, and diaphragm/limb movement 4
- Obese patients dosed by ideal body weight had longer time to maximum block and shorter clinical duration (25 vs 33 minutes) 5
- Higher fentanyl and midazolam doses are typically required in obese patients 8
Hemodynamic monitoring: The midazolam-fentanyl-rocuronium combination produces modest blood pressure reductions without significant heart rate changes 9. Hypotension (SBP <90 mmHg) occurred in 6% immediately post-induction and 16% at 9 minutes 9. Interestingly, higher rocuronium doses (≥1.4 mg/kg) showed higher first-attempt success in hypotensive patients without increased adverse events 6.